In this study, researchers aimed to quantify cancer incidence and survival for 8 Asian American and 3 Native Hawaiian/Pacific Islander ethnic groups.

Researchers evaluated changes in public trust in various sources of cancer information before, during, and after the COVID-19 pandemic.

(HealthDay News) — Updated recommendations are presented for the use of radiation therapy (RT) in pancreatic cancer in a clinical practice guideline issued by the American Society for Radiation ...

Researchers evaluated a new consensus genomic staging system in patients with newly diagnosed multiple myeloma.

In this study, researchers examined payer costs and out-of-pocket patient costs for anticancer biologic drugs compared with biosimilars following the passage of the Biologics Price Competition and ...

Researchers evaluated the efficacy of primary eye-preserving therapy versus primary enucleation in patients with early cT3c retinoblastoma.

Phase 3 SURPASS-ET data support the expanded indication of ropeginterferon alfa-2b-njft as the first new FDA-approved essential thrombocythemia therapy in nearly 3 decades.

In 2001, imatinib was the first proof that small molecule inhibitors targeting molecular drivers of cancer could be an ...

In this study, researchers evaluated the incidence and timing of TRAEs, readmissions, and transfusions after hospital discharge in patients with melanoma who received lifileucel treatment.

Investigators conducted a retrospective study to determine the association between new-onset metabolic syndrome during the first year after initiation of concurrent androgen deprivation therapy and an ...

Tumor treating fields have demonstrated efficacy and safety, especially in glioblastoma treatment, but clinical uptake ...

In this study, researchers developed and evaluated a blood-based cell-free and exosomal miRNA panel for detecting early-stage CRC and advanced adenomas.